NJ State Employees Deferred Compensation Plan - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 234 filers reported holding TG THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
NJ State Employees Deferred Compensation Plan ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$765,776
-57.5%
91,600
+26.2%
0.12%
-55.4%
Q2 2023$1,803,384
+65.2%
72,6000.0%0.26%
+53.8%
Q1 2023$1,091,904
+27.1%
72,6000.0%0.17%
+21.6%
Q4 2022$858,858
+99.7%
72,6000.0%0.14%
+87.8%
Q3 2022$430,000
+273.9%
72,600
+168.9%
0.07%
+289.5%
Q2 2022$115,000
-55.3%
27,0000.0%0.02%
-45.7%
Q1 2022$257,000
-49.9%
27,0000.0%0.04%
-46.2%
Q4 2021$513,000
-42.9%
27,0000.0%0.06%
-46.7%
Q3 2021$899,000
-14.1%
27,0000.0%0.12%
-12.2%
Q2 2021$1,047,000
-19.5%
27,0000.0%0.14%
-24.9%
Q1 2021$1,301,000
-7.4%
27,0000.0%0.18%
-14.7%
Q4 2020$1,405,000
+94.3%
27,0000.0%0.22%
+66.9%
Q3 2020$723,000
+37.5%
27,0000.0%0.13%
+31.3%
Q2 2020$526,000
+97.7%
27,0000.0%0.10%
+62.3%
Q1 2020$266,000
-11.3%
27,0000.0%0.06%
+19.6%
Q4 2019$300,000
+97.4%
27,0000.0%0.05%
+82.1%
Q3 2019$152,00027,0000.03%
Other shareholders
TG THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
M28 Capital Management LP 726,200$3,086,0003.46%
Paradigm Biocapital Advisors LP 1,964,709$8,350,0001.66%
683 Capital Management, LLC 3,300,000$14,025,0000.99%
MAVERICK CAPITAL LTD 6,747,549$28,677,0000.71%
Antara Capital LP 1,500,000$6,375,0000.27%
Parkwood LLC 47,168$1,375,0000.24%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,677,500$11,379,0000.24%
PURA VIDA INVESTMENTS, LLC 950,813$4,041,0000.24%
OCCUDO QUANTITATIVE STRATEGIES LP 567,576$2,412,0000.20%
Antara Capital LP 900,000$3,825,0000.16%
View complete list of TG THERAPEUTICS INC shareholders